Tryptophan metabolism in pregnant sheep: Increased fetal kynurenine production in response to maternal tryptophan loading

American Journal of Obstetrics and Gynecology

Volumn 181, Issue 6, 1999, Pages 1452-1460

  Nicholls, Trish ^b   Nitsos, Ilias ^b   Walker, David W ^a  

^a MONASH UNIVERSITY   (Australia)

^b NONE

Author keywords

Excitotoxicity; Fetus; Kynurenic acid; Kynurenine; Neuroprotection; Quinolinic acid; Tryptophan; Tryptophan 2,3 dioxygenase

Indexed keywords

HYDROCORTISONE; KYNURENINE; QUINOLINIC ACID; TRYPTOPHAN;

AMINO ACID ANALYSIS; AMINO ACID METABOLISM; ARTICLE; BLOOD SAMPLING; ELECTROPHYSIOLOGY; FEMALE; FETUS; GESTATIONAL AGE; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; SHEEP;

EID: 0008091344     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9378(99)70391-1     Document Type: Article

References (28)

1. 1. Bender DA. The kynurenine pathway of tryptophan metabolism. In: Stone TW, editor. Quinolinic acid and the kynurenines. Boca Raton (FL): CRC Press; 1989.
2. 2. Schwarcz R. Metabolism and function of brain kynurenines. Biochem Soc Trans 1993;21:77-82.
3. 3. Stone TW, Perkins MN. Quinolinic acid: a potent endogenous excitant at amino acid receptors in the CNS. Eur J Pharmacol 1981;72:411-2.
4. 4. Benveniste H, Drejer J, Schausboe A, Diemer NH. Elevation of the extracellular concentration of glutamate and aspartate in rat hippocampus during transient cerebellar ischaemia monitored by intracerebral microdialysis. J Neurochem 1984;43:1369-74.
5. 5. Choi DW, Rothman SM. The role of glutamate neurotoxicity in hypoxic-ischemic neuronal death. Annu Rev Neurosci 1990;13:171-82.
6. 6. Heyes MP, Saito K, Crowley JS, Davis LE, Demitrack MA, Der M, et al. Quinolinic acid and kynurenine pathway metabolism in inflammatory and non-inflammatory neurological disease. Brain 1992;115(Pt 5):1249-73.
7. 7. Walker D, Curtis B, Lacey B, Nitsos I. Kynurenic acid in brain and cerebrospinal fluid of fetal, newborn, and adult sheep and the effect of placental embolisation. Pediatr Res 1999;45:820-6.
8. 8. Peters JC. Tryptophan nutrition and metabolism: an overview. Adv Exp Med Biol 1991;294:345-58.
9. 9. Gal EM, Young RB, Sherman AD. Tryptophan loading: consequent effects on the synthesis of kynurenine and 5-hydroxyindoles in rat brain. J Neurochem 1978;31:237-44.
10. 10. Knox WE. Regulation of tryptophan pyrrolase activity by tryptophan. Adv Enzyme Regul 1955;4:287-97.
11. 11. Badany A. Effects of pregnancy on tryptophan metabolism and disposition in the rat. Biochem J 1988;255:369-72.
12. 12. Boyd R, Kudo Y. Transport functions of the placenta and fetal membranes. In: Thorburn GD, Harding R, editors. Textbook of fetal physiology. New York: Oxford University Press; 1994. p. 6-15.
13. 13. Morita I, Kawamoto M, Yoshida H. Difference in the concentration of tryptophan metabolites between maternal and umbilical foetal blood. J Chromatogr 1992;576:334-9.
14. 14. Kazda H, Taylor N, Healy D, Walker D. Maternal, umbilical and amniotic fluid concentrations of tryptophan and kynurenine after labor or caesarean section. Pediatr Res 1998;44:368-73.
15. 15. Comings DE, Muhleman D, Dietz G, Sherman M, Forest GL. Sequence of human tryptophan 2,3-dioxygenase (TDO2): presence of a glucocorticoid response-like element composed of a GTT repeat and an intronic CCCCT repeat. Genomics 1995;29:390-6.
16. 16. Bocking AD, McMillen ID, Harding R, Thorburn GD. Effect of reduced uterine blood flow on fetal and maternal cortisol. J Dev Physiol 1986;8:237-45.
17. 2 tension. Am J Physiol 1996;271:C1172-80.
18. 2 sensors in hypoxic regulation of tyrosine hydroxylase gene expression. Am J Physiol 1998;274:C167-74.
19. 19. Fukui S, Schwarcz R, Rapoport SI. Blood-brain barrier transport of kynurenines: implications for brain synthesis and metabolism. J Neurochem 1991;56:2007-17.
20. 20. Heyes MP, Achim CL, Wiley CA, Major EO, Saito K, Markey SP. Human microglia convert I.-tryptophan into the neurotoxin quinolinic acid. Biochem J 1996;320:595-7.
21. 21. Heyes MP, Chen CY, Major EO, Saito K. Different kynurenine pathway enzymes limit quinolinic acid formation by various human cell types. Biochem J 1997;326:351-6.
22. 3H] glutamate uptake into synaptosomes. J Neurochem 1986;47:1614-9.
23. 23. McDonald JW, Johnston MV. Physiological and pathophysiological roles of excitatory amino acids during central nervous system development. Brain Res Rev 1990;15:41-70.
24. 24. Miranda AF, Boegman RJ, Beninger RJ, Jhamandas K. Protection against quinolinic acid mediated excitotoxicity in nigrostriatal dopaminergic neurons by endogenous kynurenic acid. Neuroscience 1997;78:967-75.
25. 25. Andine P, Lehmann A, Eilren K, Wennberg E, Kjellmer I, Nielsen T. The excitatory amino acid antagonist kynurenic acid administered after hypoxic-ischemia in neonatal rats offers neuroprotection. Neurosci Lett 1988;90:208-12.
26. 26. Reinhard JF Jr, Flanagan EM, Madge DJ, Iyer R, Salter M. Effects of 540C91 [(E)-3-[2-(4′-pyridyl)-vinyl]-1H-indole], an inhibitor of hepatic tryptophan dioxygenase, on brain quinolinic acid in mice. Biochem Pharmacol 1996;51:159-63.
27. 27. Matsuo T, Inoue F, Takeushi Y, Kinugasa A, Sawada T. Efficacy of tryptophan for the treatment of nonkinetic hyperglycinemia: a new therapeutic approach for modulating the N-methyl-D-aspartate receptor. Pediatrics 1995;95:142-6.
28. 28. Dong-Ruyl L, Sawada M, Nakano K. Tryptophan and its metabolite, kynurenine, stimulate expression of nerve growth factor in cultured mouse astroglial cells. Neurosci Lett 1998;244:17-20.